NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘biotech’

10 February 2015

Weak start to the year for global biotech investment valuep

biotech virus lab The value of private equity, venture capital and development capital investment in the global biotechnology sector decreased in January compared to the previous month despite a rise in volume. A total of $455m was invested in biotech companies over the four weeks, down 82 per cent from a high base of $2.58bn in December according to[...]

9 January 2015

Sofinnova Ventures hires biotech veteran Welch as executive partner

Dan W_1420698769 Life sciences investor Sofinnova Ventures has hired former biotech CEO Daniel Welch as executive partner.

6 January 2015

Pfizer leads $20m Series C round in CytomX to fight cancer

health Pfizer Venture Investments has led a $20m Series C financing round in biotech firm CytomX.

27 November 2014

Idinvest seals 7.6x return exiting Prosensa through $680m buyout

Prosensa Idinvest Partners has made a 7.6-times return by exiting its stake in Dutch biotechnology business Prosensa in a deal which values the business at $680m.

11 November 2014

Parter Capital leads $4.6m Series A for Swiss biotech company

more-money-1207333-m A consortium of Swiss private investors known as Partner Capital Group has led a CHF4.5m ($4.6m) financing round for stem cell research company Histide.

5 November 2014

Clarus leads $26.5m round in biotech company Imago BioSciences

lab-751198-m Global venture capital firm Clarus Ventures has led a $26.5m Series A financing round in biotechnology firm Imago BioSciences.

8 October 2014

Waterland in talks to buy Median from Advent and Marcol

biotech lab clinic research Dutch private equity group Waterland is reportedly in talks to buy German clinic chain Median Kliniken from Advent and Marcol in a deal worth $1.26bn.

1 September 2014

Qiming leads $30m for drug developer Zai Lab

china Chinese drug development company Zai Lab has secured $30m in a Series A round led by Qiming Venture Partners.

28 August 2014

Biotech startup Armetheon raises $7m Series A

medic Menlo Park-based biopharmaceutical startup Armetheon has raised $7m in a Series A round led by AshHill Biomedical Investments and Hercules Bioventures.

26 August 2014

Gimv exits Covagen after six years

covagen Investment firm Gimv has exited its portfolio company Covagen to an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson after more than six years.

Page 1 of 1112345...10...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015